Clinical Trial Update: Efficacy and Safety of SHR3824 in Combination With Metformin in Subjects With Type 2 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating SHR3824 in combination with metformin for type 2 diabetes; efficacy and safety data are not yet public.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• SHR3824
• metformin (metformin)

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: UNKNOWN